Brenntag (BNR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
12 Aug, 2026Market leadership and business model
Holds a leading position in the global chemical distribution market, operating in over 70 countries with around 600 sites and serving approximately 160,000 customers across diverse industries.
Operates two main divisions: Essentials (industrial chemicals) and Specialties (performance chemicals and ingredients), each with distinct strategies and market approaches.
Maintains an asset-light, resilient business model with consistent ROCE above 10% and a strong track record of reliable earnings growth since IPO.
M&A is a core growth pillar, with over EUR 4.2bn spent on more than 100 acquisitions since IPO, contributing to significant revenue and earnings growth.
Focuses on value-added services, innovation, and digitalization to connect suppliers and customers, reinforcing its role as a trusted partner.
Financial performance and outlook
Q2 2026 sales reached EUR 4.3bn (+11.1% YoY), with operating EBITDA at EUR 463m (+40.9% YoY) and a conversion ratio of 40.4%.
Both divisions delivered strong margin expansion, with Essentials gross profit up 23.1% and Specialties up 8.8% YoY.
Cost-out program delivered EUR 41m in Q2 2026, targeting EUR 200-250m in savings by 2027.
Free cash flow in Q2 2026 was EUR 4m, reflecting higher working capital requirements due to elevated pricing.
Raised 2026 operating EBITDA guidance to EUR 1,350-1,450m, despite ongoing macroeconomic uncertainty and regional market volatility.
Strategic priorities and operational execution
Key priorities include sales productivity, organizational simplification, and accelerated execution of cost and efficiency measures.
Commercial initiatives and flexible pricing approaches are driving customer growth and improved profitability.
Integration of recent acquisitions and continued M&A pipeline support growth and portfolio optimization.
Essentials division leverages global scale and supply chain optimization, while Specialties focuses on innovation and value-added services.
Latest events from Brenntag
- Q2 EBITDA surged 41% and guidance was raised, despite persistent macroeconomic risks.BNR
Q2 2026 (Pre Recorded) - Q2 2026 delivered strong sales, profit growth, and raised guidance amid market volatility.BNR
Q2 2026 - Resilient Q1 2026 results, strong margins, and confirmed 2026 EBITDA guidance amid market volatility.BNR
Investor presentation - Gross margin rose to 25.9% as sales fell 5.1% and EBITDA dropped 8.3% in Q1 2026.BNR
Q1 2026 - Resilient FY 2024 performance with strong cash flow, cost-out, and sustainability leadership.BNR
Investor presentation - Gross margin and cash flow rose despite lower earnings, with cost savings and cautious outlook.BNR
Q4 2025 - Sales and gross profit rose, but EBITA, EPS, and free cash flow declined in a tough Q3.BNR
Q3 2024 - Sales, EBITA, and cash flow fell in 2024, prompting lower guidance and major acquisitions.BNR
Q2 2024 - 2024 EBITDA fell 13% to €1.1bn; 2025 outlook expects moderate recovery amid uncertainty.BNR
Q4 2024